Convergence Investment Partners, LLC Biogen Inc. Transaction History

Convergence Investment Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $972,918 - $1.46 Million	-4,118 Closed	0 $0
Q3 2020 Oct 28, 2020	BUY	$264.77 - $305.71 $6,619 - $7,642	25 Added 0.61%	4,118 $1.17 Million
Q2 2020 Jul 30, 2020	BUY	$258.66 - $342.55 $264,350 - $350,086	1,022 Added 33.28%	4,093 $1.1 Million
Q1 2020 Apr 23, 2020	SELL	$268.85 - $341.04 $522,375 - $662,640	-1,943 Reduced 38.75%	3,071 $972,000
Q4 2019 Jan 22, 2020	SELL	$220.06 - $304.07 $333,170 - $460,361	-1,514 Reduced 23.19%	5,014 $1.49 Million
Q3 2019 Oct 22, 2019	SELL	$217.44 - $243.88 $278,758 - $312,654	-1,282 Reduced 16.41%	6,528 $1.52 Million
Q2 2019 Jul 23, 2019	SELL	$219.29 - $241.72 $85,303 - $94,029	-389 Reduced 4.74%	7,810 $1.83 Million
Q1 2019 May 01, 2019	SELL	$216.71 - $338.96 $19,937 - $31,184	-92 Reduced 1.11%	8,199 $1.94 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $426,662 - $540,413	1,532 Added 22.67%	8,291 $2.5 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $1.43 Million - $1.87 Million	-4,883 Reduced 41.94%	6,759 $2.39 Million
Q2 2018 Aug 07, 2018	BUY	$257.52 - $306.91 $2.89 Million - $3.45 Million	11,241 Added 2803.24%	11,642 $3.38 Million
Q1 2018 May 14, 2018	BUY	$260.13 - $367.91 $104,312 - $147,531	401 New	401 $110,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Convergence Investment Partners, LLC with notifications on news.